DBV Technologies S.A. Company Profile (NASDAQ:DBVT)

About DBV Technologies S.A. (NASDAQ:DBVT)

DBV Technologies S.A. logoDBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The Company's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The Company operates one subsidiary DBV Technologies Inc. in the United States.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Diagnostic & Testing Substances Manufacturers
  • Sub-Industry: N/A
  • Symbol: NASDAQ:DBVT
  • CUSIP: N/A
  • Web: www.dbv-technologies.com
Capitalization:
  • Market Cap: $2 billion
  • Outstanding Shares: 46,000,000
Average Prices:
  • 50 Day Moving Avg: $44.06
  • 200 Day Moving Avg: $37.85
  • 52 Week Range: $31.87 - $46.33
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -9.84
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $11.41 million
  • Price / Sales: 175.01
  • Book Value: $4.66 per share
  • Price / Book: 9.32
Profitability:
  • EBIDTA: ($163,340,000.00)
Debt:
  • Debt-to-Equity Ratio: 0.02%
  • Current Ratio: 6.75%
  • Quick Ratio: 9.39%
Misc:
  • Average Volume: 147,139 shs.
  • Beta: 1.53
  • Short Ratio: 3.18
 

Frequently Asked Questions for DBV Technologies S.A. (NASDAQ:DBVT)

What is DBV Technologies S.A.'s stock symbol?

DBV Technologies S.A. trades on the NASDAQ under the ticker symbol "DBVT."

How were DBV Technologies S.A.'s earnings last quarter?

DBV Technologies S.A. (NASDAQ:DBVT) released its earnings results on Thursday, March, 26th. The company reported ($0.79) earnings per share for the quarter, missing the consensus estimate of ($0.44) by $0.35. View DBV Technologies S.A.'s Earnings History.

Where is DBV Technologies S.A.'s stock going? Where will DBV Technologies S.A.'s stock price be in 2017?

8 brokers have issued 1-year price targets for DBV Technologies S.A.'s shares. Their predictions range from $46.00 to $60.00. On average, they anticipate DBV Technologies S.A.'s stock price to reach $50.80 in the next twelve months. View Analyst Ratings for DBV Technologies S.A..

Who are some of DBV Technologies S.A.'s key competitors?

Who are DBV Technologies S.A.'s key executives?

DBV Technologies S.A.'s management team includes the folowing people:

  • Pierre-Henri Benhamou, Chairman of the Board, Chief Executive Officer
  • David Schilansky, Chief Operating Officer
  • Hugh A. Sampson M.D., Chief Scientific Officer
  • Lucie Mondoulet, Director of Research
  • Nathalie Donne, Director of Corporate Communication & Business Development
  • Veronique Foutel, Director of Strategic Marketing
  • Wence Agbotounou, Chief Clinical Trial Officer
  • Bertrand Dupont, Industrial Director
  • Pascale Ehouarn, Industrial Development and Production Director
  • Laurent Martin, Director of Regulatory Affairs

Who owns DBV Technologies S.A. stock?

DBV Technologies S.A.'s stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include FMR LLC (6.54%), Janus Henderson Group PLC (5.52%), Jennison Associates LLC (2.18%), Alliancebernstein L.P. (2.17%), TimesSquare Capital Management LLC (2.02%) and Oak Ridge Investments LLC (1.82%). View Institutional Ownership Trends for DBV Technologies S.A..

Who sold DBV Technologies S.A. stock? Who is selling DBV Technologies S.A. stock?

DBV Technologies S.A.'s stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, First Manhattan Co., TimesSquare Capital Management LLC, Oak Ridge Investments LLC, Emory University, Artisan Partners Limited Partnership, Goldman Sachs Group Inc. and Parametric Portfolio Associates LLC. View Insider Buying and Selling for DBV Technologies S.A..

Who bought DBV Technologies S.A. stock? Who is buying DBV Technologies S.A. stock?

DBV Technologies S.A.'s stock was acquired by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Jennison Associates LLC, Botty Investors LLC, Sectoral Asset Management Inc, Sit Investment Associates Inc., Airain ltd, Dynamic Technology Lab Private Ltd and Exane Asset Management. View Insider Buying and Selling for DBV Technologies S.A..

How do I buy DBV Technologies S.A. stock?

Shares of DBV Technologies S.A. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is DBV Technologies S.A.'s stock price today?

One share of DBV Technologies S.A. stock can currently be purchased for approximately $43.41.


MarketBeat Community Rating for DBV Technologies S.A. (NASDAQ DBVT)
Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  145 (Vote Outperform)
Underperform Votes:  102 (Vote Underperform)
Total Votes:  247
MarketBeat's community ratings are surveys of what our community members think about DBV Technologies S.A. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for DBV Technologies S.A. (NASDAQ:DBVT) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 8 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $50.80 (17.02% upside)

Analysts' Ratings History for DBV Technologies S.A. (NASDAQ:DBVT)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/12/2017Jefferies Group LLCReiterated RatingBuy$51.00LowView Rating Details
8/25/2017Leerink SwannBoost Price TargetOutperform$54.00 -> $60.00LowView Rating Details
7/10/2017Morgan StanleyReiterated RatingOverweightLowView Rating Details
7/6/2017HC WainwrightReiterated RatingBuy$50.00MediumView Rating Details
6/23/2017Deutsche Bank AGInitiated CoverageBuy$46.00LowView Rating Details
3/16/2017Societe GeneraleUpgradeHold -> BuyMediumView Rating Details
2/17/2017NatixisUpgradeNeutral -> BuyN/AView Rating Details
9/26/2016JMP SecuritiesInitiated CoverageOutperform$47.00N/AView Rating Details
3/16/2016Citigroup Inc.Lower Price TargetBuy$48.00 -> $43.00N/AView Rating Details
12/3/2015Barclays PLCInitiated CoveragePositive -> Overweight$58.00N/AView Rating Details
10/23/2015Bank of America CorporationInitiated CoverageBuy$48.00N/AView Rating Details
(Data available from 9/24/2015 forward)

Earnings

Earnings History for DBV Technologies S.A. (NASDAQ:DBVT)
Earnings by Quarter for DBV Technologies S.A. (NASDAQ:DBVT)
Earnings History by Quarter for DBV Technologies S.A. (NASDAQ DBVT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/26/2015($0.44)($0.79)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for DBV Technologies S.A. (NASDAQ:DBVT)
2017 EPS Consensus Estimate: ($4.00)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.91)($0.91)($0.91)
Q2 20171($1.00)($1.00)($1.00)
Q3 20171($1.04)($1.04)($1.04)
Q4 20171($1.05)($1.05)($1.05)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for DBV Technologies S.A. (NASDAQ:DBVT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for DBV Technologies S.A. (NASDAQ:DBVT)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for DBV Technologies S.A. (NASDAQ:DBVT)
Latest Headlines for DBV Technologies S.A. (NASDAQ:DBVT)
Source:
DateHeadline
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - September 24 at 12:42 AM
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Lifted to Buy at Zacks Investment Research
www.americanbankingnews.com - September 18 at 5:46 PM
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Receives Buy Rating from Jefferies Group LLC
www.americanbankingnews.com - September 17 at 9:34 PM
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Cut to Hold at Zacks Investment Research
www.americanbankingnews.com - September 14 at 6:06 PM
seekingalpha.com logoDBV Technologies' (DBVT) Management on Morgan Stanley 15th Annual Global Healthcare Conference - Transcript
seekingalpha.com - September 12 at 11:34 PM
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - September 12 at 5:40 PM
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Cut to "Hold" at Zacks Investment Research
www.americanbankingnews.com - September 8 at 10:34 PM
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Downgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - August 31 at 10:38 PM
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Receives "Buy" Rating from Jefferies Group LLC
www.americanbankingnews.com - August 31 at 6:56 PM
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - August 30 at 12:44 AM
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - August 29 at 6:30 PM
finance.yahoo.com logoDBV Technologies Announces Completion of Enrollment in Phase III Extension Study of Viaskin Peanut
finance.yahoo.com - August 29 at 3:42 AM
americanbankingnews.com logoLeerink Swann Raises DBV Technologies S.A. (DBVT) Price Target to $60.00
www.americanbankingnews.com - August 25 at 9:54 AM
americanbankingnews.com logoBidaskClub Upgrades DBV Technologies S.A. (DBVT) to Buy
www.americanbankingnews.com - August 22 at 10:40 PM
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Downgraded by BidaskClub to "Hold"
www.americanbankingnews.com - August 13 at 1:02 PM
americanbankingnews.com logoDBV Technologies S.A. (NASDAQ:DBVT) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - August 5 at 12:38 AM
finance.yahoo.com logoDBV Technologies Initiates Phase III Study of Viaskin Peanut in Peanut-Allergic Patients One to Three Years of Age
finance.yahoo.com - August 2 at 4:34 AM
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Upgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - August 1 at 5:56 PM
finance.yahoo.com logoDBV Technologies Reports First Half 2017 Financial Results
finance.yahoo.com - July 28 at 4:10 AM
americanbankingnews.com logoDBV Technologies S.A. (NASDAQ:DBVT) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - July 11 at 12:20 AM
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Earns "Overweight" Rating from Morgan Stanley
www.americanbankingnews.com - July 10 at 9:40 PM
finance.yahoo.com logoDBV Technologies (DBVT) Worth a Look: Stock Up 5.7%
finance.yahoo.com - July 10 at 5:47 PM
americanbankingnews.com logoDBV Technologies' (DBVT) "Buy" Rating Reaffirmed at HC Wainwright
www.americanbankingnews.com - July 6 at 4:04 PM
finance.yahoo.com logoHalf-Year Report on the DBV Technologies Liquidity Contract with Natixis
finance.yahoo.com - July 5 at 6:29 PM
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Cut to "Sell" at ValuEngine
www.americanbankingnews.com - July 1 at 10:04 AM
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Rating Increased to Hold at ValuEngine
www.americanbankingnews.com - June 24 at 10:22 PM
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Coverage Initiated at Deutsche Bank AG
www.americanbankingnews.com - June 23 at 12:12 PM
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Upgraded at BidaskClub
www.americanbankingnews.com - June 21 at 8:18 PM
americanbankingnews.com logoHead-To-Head Comparison: DBV Technologies (DBVT) and Meridian Bioscience (VIVO)
www.americanbankingnews.com - June 20 at 10:31 AM
americanbankingnews.com logo Analysts Expect DBV Technologies S.A. (DBVT) to Post -$0.91 Earnings Per Share
www.americanbankingnews.com - June 19 at 8:16 AM
americanbankingnews.com logoQuidel Corporation (QDEL) versus DBV Technologies (DBVT) Financial Comparison
www.americanbankingnews.com - June 18 at 7:24 AM
finance.yahoo.com logoDBV Technologies Highlights Poster Presentations on EPIT® at the 2017 EAACI Congress
finance.yahoo.com - June 17 at 3:36 AM
finance.yahoo.com logoDBV Technologies Announces Appointment of Julie O`Neill to Board of Directors
finance.yahoo.com - June 16 at 6:30 AM
americanbankingnews.com logoBidaskClub Downgrades DBV Technologies S.A. (DBVT) to Strong Sell
www.americanbankingnews.com - June 14 at 9:06 PM
americanbankingnews.com logoDBV Technologies S.A. (DBVT) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - June 14 at 12:46 AM
finance.yahoo.com logoDBV Technologies : Ordinary and Extraordinary General Meeting of June 15, 2017 Procedures for Obtaining Preparatory Documents for the General Meeting
finance.yahoo.com - May 24 at 11:19 PM
americanbankingnews.com logoDBV Technologies SA - (DBVT) Expected to Earn Q2 2017 Earnings of ($1.00) Per Share
www.americanbankingnews.com - May 22 at 7:12 AM
americanbankingnews.com logoDBV Technologies SA - (DBVT) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 20 at 12:12 AM
finance.yahoo.com logoDBV Technologies Highlights Research Presentation of EPIT® for the Treatment of Crohn's Disease at Digestive Disease Week 2017
finance.yahoo.com - May 8 at 9:29 AM
americanbankingnews.com logo Brokerages Expect DBV Technologies SA - (DBVT) to Announce -$0.91 Earnings Per Share
www.americanbankingnews.com - May 1 at 10:07 AM
americanbankingnews.com logoDBV Technologies SA - (DBVT) Earning Positive Media Coverage, Analysis Finds
www.americanbankingnews.com - April 29 at 9:02 AM
finance.yahoo.com logoDBV Technologies Reports March 31, 2017 Cash Position
finance.yahoo.com - April 28 at 3:14 AM
americanbankingnews.com logoDBV Technologies SA - (DBVT) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - April 25 at 12:53 AM
americanbankingnews.com logoDBV Technologies SA - (DBVT) Rating Increased to Hold at Zacks Investment Research
www.americanbankingnews.com - April 24 at 7:14 PM
americanbankingnews.com logoDBV Technologies SA - (DBVT) Short Interest Update
www.americanbankingnews.com - April 24 at 5:53 PM
americanbankingnews.com logoDBV Technologies SA - (DBVT) Given Daily Media Impact Score of 0.31
www.americanbankingnews.com - April 23 at 6:35 PM
americanbankingnews.com logoDBV Technologies SA - (DBVT) Receiving Favorable Media Coverage, Report Shows
www.americanbankingnews.com - April 20 at 4:56 PM
americanbankingnews.com logoDBV Technologies SA - (DBVT) Earns Daily Coverage Optimism Score of 0.56
www.americanbankingnews.com - April 17 at 12:28 PM
americanbankingnews.com logoZacks: Brokerages Expect DBV Technologies SA - (DBVT) Will Post Earnings of -$0.91 Per Share
www.americanbankingnews.com - April 8 at 12:22 AM
finance.yahoo.com logoDBV Technologies to Attend the 10th Kempen Life Sciences Conference
finance.yahoo.com - April 7 at 9:23 AM

Social

Chart

DBV Technologies S.A. (DBVT) Chart for Sunday, September, 24, 2017

This page was last updated on 9/24/2017 by MarketBeat.com Staff